1
|
Meunier B, Jourde-Chiche N, Mancini J, Chekroun M, Retornaz F, Chiche L. Characteristics and information searched for by French patients with systemic lupus erythematosus: A web-community data-driven online survey. Lupus 2015; 25:370-5. [DOI: 10.1177/0961203315610644] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2015] [Accepted: 09/16/2015] [Indexed: 11/15/2022]
Abstract
Introduction To provide information about the needs of patients with systemic lupus erythematosus (SLE) using Carenity, the first European online platform for patients with chronic diseases. Methods At one year after its creation, all posts from the Carenity SLE community were collected and analysed. A focused cross-sectional online survey was performed. Results The SLE community included 521 people (93% females; mean age: 39.8 years). Among a total of 6702 posts, 2232 were classified according to disease-related topics. The 10 most common topics were ‘lupus and …’ either ‘treatment’, ‘fatigue’, ‘entourage’, ‘sun exposure’, ‘diagnosis’, ‘autoimmune diseases’, ‘pregnancy’, ‘contraception’, ‘symptoms’ or ‘sexuality’. 112 SLE patients participated in the online survey. At the time of diagnosis, only 17 (15%) patients had heard of SLE and 84 (75%) expressed a need for more information on outcomes (27%), treatments (27%), daily life (14%), patients' associations (11%), symptoms (8%), the disease (8%) and psychosocial aspects (7%). When treatment was initiated, 48 patients (43%) would have liked more information about side effects (46%), long-term effects (21%), treatment duration/cessation (12.5%) and type (10%) and mechanism of action (8%) of treatments. All participants except one had used the internet to find information about SLE. Sources of information included healthcare providers (51%/61%/67%), journals/magazines (7%/12%/6%), lupus Websites (51%/77%/40%), web forums/blogs (34%/53%/19%), patients' associations (11%/23%/9%) accessed at ‘just before diagnosis’, ‘just after diagnosis’ and ‘before treatment initiation’. Conclusions Online patient communities provide original unbiased information that can help improve provision of information to SLE patients.
Collapse
Affiliation(s)
- B Meunier
- Service de Médecine Interne, Hôpital de la Conception, Université Aix-Marseille, Marseille, France
| | - N Jourde-Chiche
- Service de Néphrologie, Hôpital de la Conception, Université Aix-Marseille, Marseille, France
| | - J Mancini
- Service de Biostatistiques et Technologie de l’Information et de la Communication (BIOSTIC), Hôpital de la Timone, APHM; Université Aix-Marseille, UMR S912, Inserm, IRD, SESSTIM, Marseille, France
| | | | - F Retornaz
- Service de Médecine Interne, Hôpital Européen, Marseille, France
| | - L Chiche
- Service de Médecine Interne, Hôpital Européen, Marseille, France
| |
Collapse
|
2
|
Schneider M, Haupt M. [Overcoming disease in systemic lupus erythematosus]. Z Rheumatol 2015; 74:591-6. [PMID: 26286190 DOI: 10.1007/s00393-014-1556-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease affecting a broad range of different organ systems and, hence, presenting with multiple symptomatic domains, which considerably reduces the quality of life of patients. Within the last decade the prognosis of the disease has been significantly improved by novel therapies and intensive monitoring; however, non-pharmaceutical strategies for symptom control, self-efficacy and coping abilities for those affected are still insufficiently established. OBJECTIVE This article describes the possibilities and limitations of non-pharmaceutical strategies and makes suggestions for future treatment and research. RESULTS Preliminary interventional studies using psychoeducational, psychosocial and behavioral psychotherapeutic approaches, have consistently shown that the needs and expectations of patients related to help and support by doctors and professional care can be adequately and sustainably met. In addition, coping abilities and the quality of life can be increased.
Collapse
Affiliation(s)
- M Schneider
- Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland,
| | | |
Collapse
|
3
|
Hervier B, Magar Y, Allab F, Richard K, Neves Y, Danjou S, Amoura Z, Ayçaguer S. [Patients' intervention in a therapeutic education program dedicated to systemic lupus: definitions, setting and benefits]. Rev Med Interne 2015; 36:645-50. [PMID: 26045337 DOI: 10.1016/j.revmed.2015.04.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2015] [Revised: 03/26/2015] [Accepted: 04/24/2015] [Indexed: 01/04/2023]
Abstract
PURPOSE Though recommended, participation of patients with specific expertise in therapeutic education programs (TEP) is rare. This work reports the experience of a national reference centre for rare systemic diseases. PATIENTS AND METHODS Involvement of "expert patients" (EP) has been planned from the development of a TEP dedicated to systemic lupus: patients' roles and required expertise have been defined and linked to the pedagogical tools. Such patients have been recruited during individual interviews and called to participate to specific pedagogical training. EP intervention have been evaluated by questionnaire to EP and health care providers. RESULTS Three EP's functions have been identified: sharing experiences, giving "tips and tricks" and promoting dialogue. EP's interventions has been organised into a hierarchy (from sharing to co-animation). Among 298 patients enrolled in the TEP, 25 (8.4%) have been identified as possible EP. Eight of them (32%) benefited from a specific training of 12 hours. Among these patients, two (25%) regularly participate to the education sessions. For EP as well as for health care providers, EP's intervention seems beneficial (visual scale scores of 7.5 and 9.5, respectively). CONCLUSIONS Though difficult to organise, EP's intervention in TEP dedicated to rare systemic diseases seems useful and would earn to be increase.
Collapse
Affiliation(s)
- B Hervier
- UPMC, service de médecine interne, centre national de référence du lupus et du syndrome des antiphospholipides, hôpital Pitié-Salpêtrière, Institut E3M, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
| | - Y Magar
- EDU-Santé, 92170 Vanves, France
| | - F Allab
- UPMC, service de médecine interne, centre national de référence du lupus et du syndrome des antiphospholipides, hôpital Pitié-Salpêtrière, Institut E3M, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France
| | - K Richard
- UPMC, service de médecine interne, centre national de référence du lupus et du syndrome des antiphospholipides, hôpital Pitié-Salpêtrière, Institut E3M, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France
| | - Y Neves
- UPMC, service de médecine interne, centre national de référence du lupus et du syndrome des antiphospholipides, hôpital Pitié-Salpêtrière, Institut E3M, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France
| | - S Danjou
- UPMC, service de médecine interne, centre national de référence du lupus et du syndrome des antiphospholipides, hôpital Pitié-Salpêtrière, Institut E3M, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France
| | - Z Amoura
- UPMC, service de médecine interne, centre national de référence du lupus et du syndrome des antiphospholipides, hôpital Pitié-Salpêtrière, Institut E3M, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France
| | | |
Collapse
|
4
|
Théaudin M, Cauquil C, Antonini T, Algalarrondo V, Labeyrie C, Aycaguer S, Clément M, Kubezyk M, Nonnez G, Morier A, Bourges C, Darras A, Mouzat L, Adams D. Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, "EdAmyl". Amyloid 2014; 21:225-30. [PMID: 25069833 DOI: 10.3109/13506129.2014.941463] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
BACKGROUND Transthyretin-related amyloidosis (ATTR) is an autosomal dominant disease affecting the peripheral and autonomic nervous system, heart, eyes and kidneys. It is the most disabling hereditary polyneuropathy in adults. The French National Reference centre for this disease was accredited in 2005 with 10 lines of action. One of them is to inform and educate patients about their disease to improve their care and reduce morbidities. We thus decided to elaborate a therapeutic patient education (TPE) programme, starting with patients' needs assessment. METHODS A qualitative research study was conducted with one-to-one semi-structured interviews of selected individuals. Recorded interviews were analysed to identify the skills that patients need to acquire. A TPE programme was elaborated on the basis of these findings. RESULTS Seven patients, one asymptomatic carrier and two healthy spouses were interviewed. Analysis of the interviews showed that interviewees had a good knowledge of the disease and its symptoms but they had difficulties explaining the disease mechanism and did not have an adequate knowledge of the available treatment options, although they knew that liver transplant might halt progression of the disease. ATTR amyloidosis appeared to have a major negative impact on the patient's physical and mental well-being. Patients feared loss of autonomy and having to require assistance from their relatives and spouses. All interviewees were keen to participate in a TPE programme. Based on this needs assessment, we identified seven skills that patients need to acquire and several pedagogical goals to be achieved during the education programme. An interdisciplinary team then elaborated a complete TPE programme. CONCLUSION Elaboration of a TPE programme for ATTR amyloidosis required to obtain useful information from the patients themselves, and their relatives, concerning their perception of their disease. This needs' assessment constituted the basis for designing the first TPE programme, to our knowledge, for ATTR amyloidosis. After translation, this programme could be applied in other EU countries and worldwide for this rare disease.
Collapse
Affiliation(s)
- Marie Théaudin
- French Reference Centre for Familial Amyloid Polyneuropathy, NNerf, Neurology Department, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris (APHP), HUPS , Le Kremlin-Bicêtre, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|